These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11219769

  • 41. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
    Mittal RD, Mandal RK, Gangwar R.
    Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
    [Abstract] [Full Text] [Related]

  • 42. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
    Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, Nishioka NS, Lynch TJ, Christiani DC.
    Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
    [Abstract] [Full Text] [Related]

  • 43. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
    Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
    [Abstract] [Full Text] [Related]

  • 44. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review.
    Hung RJ, Hall J, Brennan P, Boffetta P.
    Am J Epidemiol; 2005 Nov 15; 162(10):925-42. PubMed ID: 16221808
    [Abstract] [Full Text] [Related]

  • 45. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P.
    Carcinogenesis; 2004 Dec 15; 25(12):2433-41. PubMed ID: 15333465
    [Abstract] [Full Text] [Related]

  • 46. Genetic polymorphisms in DNA repair gene APE1, XRCC1 and XPD and the risk of pre-eclampsia.
    Vural P, Değirmencioğlu S, Doğru-Abbasoğlu S, Saral NY, Akgül C, Uysal M.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 15; 146(2):160-4. PubMed ID: 19592152
    [Abstract] [Full Text] [Related]

  • 47. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk.
    Han J, Hankinson SE, De Vivo I, Spiegelman D, Tamimi RM, Mohrenweiser HW, Colditz GA, Hunter DJ.
    Cancer Res; 2003 Dec 01; 63(23):8536-41. PubMed ID: 14679022
    [Abstract] [Full Text] [Related]

  • 48. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE.
    Br J Cancer; 2005 Jun 20; 92(12):2262-5. PubMed ID: 15886698
    [Abstract] [Full Text] [Related]

  • 49. Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk.
    Ratnasinghe DL, Yao SX, Forman M, Qiao YL, Andersen MR, Giffen CA, Erozan Y, Tockman MS, Taylor PR.
    Anticancer Res; 2003 Jun 20; 23(1B):627-32. PubMed ID: 12680158
    [Abstract] [Full Text] [Related]

  • 50. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.
    Cancer Res; 1998 Feb 15; 58(4):667-71. PubMed ID: 9485019
    [Abstract] [Full Text] [Related]

  • 51. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
    Broberg K, Björk J, Paulsson K, Höglund M, Albin M.
    Carcinogenesis; 2005 Jul 15; 26(7):1263-71. PubMed ID: 15746160
    [Abstract] [Full Text] [Related]

  • 52. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X.
    Carcinogenesis; 2007 Mar 15; 28(3):698-703. PubMed ID: 17052994
    [Abstract] [Full Text] [Related]

  • 53. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
    Lao T, Gu W, Huang Q.
    Mutagenesis; 2008 Nov 15; 23(6):523-32. PubMed ID: 18765423
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H.
    Mutat Res; 2007 Jul 28; 631(2):101-10. PubMed ID: 17531525
    [Abstract] [Full Text] [Related]

  • 56. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
    Kiyohara C, Takayama K, Nakanishi Y.
    Lung Cancer; 2006 Dec 28; 54(3):267-83. PubMed ID: 16982113
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.
    Carcinogenesis; 2003 Oct 28; 24(10):1671-6. PubMed ID: 12844488
    [Abstract] [Full Text] [Related]

  • 59. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB.
    Cancer Epidemiol Biomarkers Prev; 2006 Feb 28; 15(2):306-11. PubMed ID: 16492920
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.